M23-515 Ph2 AD Global Study
ClinicalTrials.gov NCT05771428
Research payments
$24,375
Through program year 2024, $24,375 in research payments was reported against M23-515 Ph2 AD Global Study, across 29 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05771428
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $24,375 | 29 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Peter McAllister Fairfield, CT Named on 1 payment
- Michael Pfeffer Miami, FL Named on 1 payment
- Stephanie Rutrick Boston, MA Named on 1 payment
- David Watson Fort Hood, TX Named on 1 payment
- Neeraj Gupta Pomona, CA Named on 1 payment
- Brandon Lenox Maitland, FL Named on 1 payment
- Diana Kerwin Dallas, TX Named on 1 payment
- Antonela Svetic Beavercreek, OH Named on 1 payment
- Lealani Acosta Nashville, TN Named on 1 payment
- Joel Vandersluis Dayton, OH Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.